DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Odalasvir

Generic Name: Odalasvir

Drug Type: Small Molecule

Chemical Formula: C_₆₀H_₇₂N_₈O_₆

CAS Number: 1415119-52-6

Unique Ingredient Identifier: OVR52K7BDW

Overview

Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.

Background

Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

Phase 1

Terminated

Posted: 2017/02/23

Sponsor:Janssen Research & D...

A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Phase 2

Completed

Posted: 2016/12/15

Sponsor:Janssen Pharmaceutic...

A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir

Phase 1

Completed

Posted: 2016/11/11

Sponsor:Janssen Research & D...

A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants

Phase 1

Completed

Posted: 2016/10/26

Sponsor:Janssen Research & D...

A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants

Phase 1

Completed

Posted: 2016/09/05

Sponsor:Janssen Research & D...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy